OrbiMed Advisors LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
OrbiMed Advisors LLC
CRD #118608
SEC #801-61046
CIK #0001055951, 0001491569
AUM $17.3 B (2025-07-23)
Employees 118 (73% Investors, 0% Brokers)
Phone212-739-6400
Address601 Lexington Avenue
New York, NY 10022
Source [IAPD] [EDGAR] [Website] [LinkedIn] [Facebook]
Total AUM ($B)
25201510502002201020182026
Sector Form 13F Holdings Value ($B)
Boston Scientific Corp 0.3
Lilly Eli & Co 0.3
Edgewise Therapeutics Inc 0.2
Imara Inc 0.2
Intuitive Surgical Inc 0.2
Silverback Therapeutics Inc 0.1
Stryker Corp 0.1
Edwards Lifesciences Corp 0.1
UnitedHealth Group Inc 0.1
Argenx SE 0.1
View All
Holdings by Sector ($B)
151296302012201620212026
Type Form D Funds Date Sold ($M) AUM ($M)
PE OrbiMed Royalty & Credit Opportunities IV Offshore LP [2023-02-28] 344.5 615.9
HF OrbiMed Partners SPV Ltd 2022-11-14 130.1
Other OrbiMed Asia Partners V LP [2022-08-03] 651.9 756.5
Other OrbiMed Private Investments IX LP [2022-08-03] 1,849.5 2,026.4
PE OrbiMed Royalty & Credit Opportunities IV LP [2022-08-03] 1,153.1 1,508.5
Other OrbiMed Private Investments VIII LP [2020-11-25] 0.0 1,691.2
HF OrbiMed New Horizons Master Fund LP [2020-08-21] 61.6 33.9
Other OrbiMed Asia Partners IV LP [2020-05-22] 0.0 1,052.0
HF OrbiMed Genesis Master Fund LP [2020-02-05] 134.9 556.9
PE OrbiMed Royalty & Credit Opportunities III LP [2019-05-23] 889.8 630.0
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 31 17.3
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 31 17.3
By Discretionary
Discretionary 31 17.3
Non-Discretionary 0 0.0
Total 31 17.3
By Non-United States Persons
Non-United States Persons 8.9
United States Persons 8.4
Total 31 17.3
Limited Partners2011 - 2025
California State Teachers' Retirement System
Oregon Public Employees Retirement Fund
Form D Directors # Filings # Firms 2011 - 2025
Brian Burkholder 71
John Collis 96
David Wang 37
Jonathan Wang 41
Samuel Isaly 21
Carl Gordon 106
Peter Thompson 58
Jonathan Silverstein 57
David Bonita 50
Sven Borho 25
View All
EDGAR Form CIK 2011 - 2025
13F-HR [0001055951]
3 [0001055951]
4 [0001055951]
SC 13D [0001055951]
SC 13G [0001055951]
3 [0001491569]
4 [0001491569]
Form 13D/13G Filer Form 13D/13G Subject Filed
OrbiMed Advisors LLC CytomX Therapeutics Inc [2025-08-14]
OrbiMed Advisors LLC Whitehawk Therapeutics Inc [2025-05-15]
OrbiMed Advisors LLC ADC Therapeutics Sa [2025-02-14]
OrbiMed Advisors LLC Forte Biosciences Inc [2025-02-14]
OrbiMed Advisors LLC RAPT Therapeutics Inc [2025-02-14]
OrbiMed Advisors LLC Sionna Therapeutics Inc [2025-02-13]
OrbiMed Advisors LLC Corbus Pharmaceuticals Holdings Inc [2024-11-14]
OrbiMed Advisors LLC Avalo Therapeutics Inc [2024-11-14]
OrbiMed Advisors LLC C4 Therapeutics Inc [2024-11-14]
OrbiMed Advisors LLC Lomond Therapeutics Holdings Inc [2024-11-08]
View All
Form 3/4/5 Subject 2011 - 2025
Turnstone Biologics Corp.
OrbiMed Capital GP VI LLC
OrbiMed Advisors LLC
OrbiMed Genesis GP LLC
Ikena Oncology, Inc.
Corvus Pharmaceuticals, Inc.
OrbiMed Capital GP V LLC
OrbiMed Capital GP VII LLC
Passage BIO, Inc.
NeuroPace Inc
Xtant Medical Holdings, Inc.
Orbimed ROF II LLC
Compass Therapeutics, Inc.
Edgewise Therapeutics, Inc.
Disc Medicine, Inc.
OrbiMed Capital GP VIII LLC
MBX Biosciences, Inc.
Sionna Therapeutics, Inc.
Traws Pharma, Inc.
OrbiMed Capital GP IX LLC
Lomond Therapeutics Holdings, Inc.
Upstream Bio, Inc.
OrbiMed Advisors Israel II Ltd
OrbiMed Israel GP II, L.P.
ARS Pharmaceuticals, Inc.
OrbiMed Capital LLC
scPharmaceuticals Inc.
Keros Therapeutics, Inc.
OrbiMed Advisors III Ltd
OrbiMed Asia GP III, L.P.
Terns Pharmaceuticals, Inc.
TELA Bio, Inc.
OrbiMed Capital GP IV LLC
Alpine Immune Sciences Inc
Enliven Therapeutics, Inc.
OrbiMed Asia GP IV, L.P.
OrbiMed Advisors IV Ltd
Kinnate Biopharma Inc.
Q32 Bio Inc.
Theseus Pharmaceuticals, Inc.
ArriVent BioPharma, Inc.
Adicet Bio, Inc.
OrbiMed Israel GP Ltd.
OrbiMed Israel BioFund GP Limited Partnership
PMV Pharmaceuticals, Inc.
Galecto, Inc.
Chimovits Erez
Prelude Therapeutics Inc
Verona Pharma plc
Tricida, Inc.
Third Harmonic Bio, Inc.
SpringWorks Therapeutics, Inc.
Sierra Oncology, Inc.
Arcutis Biotherapeutics, Inc.
89bio, Inc.
Janux Therapeutics, Inc.
Repare Therapeutics Inc.
Acutus Medical, Inc.
Synlogic Inc
Oric Pharmaceuticals, Inc.
Decibel Therapeutics, Inc.
Prevail Therapeutics Inc.
CTI Biopharma Corp
Whitehawk Therapeutics, Inc.
LogicBio Therapeutics, Inc.
CalciMedica, Inc.
Inspire Medical Systems, Inc.
Pandion Therapeutics, Inc.
Fusion Pharmaceuticals Inc.
Alector, Inc.
OrbiMed Global Healthcare GP LLC
Principia Biopharma Inc.
NextCure, Inc.
Turning Point Therapeutics, Inc.
Avedro Inc
Synthorx, Inc.
SI-BONE, Inc.
Guardant Health, Inc.
Arvinas Inc
SteadyMed Ltd.
ViewRay, Inc.
OrbiMed Capital GP III LLC
Constellation Pharmaceuticals Inc
Crinetics Pharmaceuticals, Inc.
ARMO BioSciences, Inc.
Adaptimmune Therapeutics PLC
Rhythm Pharmaceuticals Inc
Palvella Therapeutics Inc
Audentes Therapeutics, Inc.
GLAUKOS Corp
KALA BIO, Inc.
Isaly Samuel D
Loxo Oncology, Inc.
X4 Pharmaceuticals, Inc
Sorrento Tech, Inc.
Spyre Therapeutics, Inc.
Nabriva Therapeutics plc
OrbiMed Asia GP LP
Response Biomedical Corp
OrbiMed Advisors Ltd
Relypsa Inc
Cartesian Therapeutics, Inc.
Intellia Therapeutics, Inc.
Otonomy Inc
Dimension Therapeutics, Inc.
Project Sage Oldco Inc
OrbiMed Private Investments V, LP
Intercept Pharmaceuticals Inc
Mirati Therapeutics, Inc.
Acceleron Pharma Inc
OrbiMed Capital GP II LLC
Ambit Biosciences Corp
Supernus Pharmaceuticals Inc
Anthera Pharmaceuticals Inc
Amarin Corp PLC UK
Complete Genomics Inc
Pacira BioSciences, Inc.
ChemoCentryx, Inc.
OrbiMed Capital GP I LLC
Comparable Firms State AUM ($B)
Dawson Partners Inc
18.4
AGL Credit Management LLC
NY 18.2
Omers Infrastructure US Limited
NY 17.9
The Rock Creek Group LP
DC 17.5
New Holland Capital LLC
NY 17.5
BlackRock Alternatives Management LLC
NY 17.4
Saba Capital Management LP
NY 17.0
First Eagle Alternative Credit LLC
MA 16.8
AIP LLC
NY 16.4
Deerfield Management Company LP Series C
NY 16.1
Terms | Privacy | Guide
tony@aum13f.com